Biotechnology

Turnstone Biologics

Turnstone Biologics released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2399 (forecast USD -0.16)

Turnstone Biologics released FY2025 Q1 earnings on May 8 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5102 (forecast USD -0.26)

Turnstone Biologics Corp. Releases Q1 2025 Earnings and Explores Strategic Options

Turnstone Biologics released FY2024 annual earnings on March 29 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -3.0749 USD (forecast -3.21 USD)

Turnstone Biologics released FY2024 Q4 earnings on March 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5582 (forecast USD -0.69)

Turnstone Biologics released FY2024 9 Months Earnings on November 12 (EST), with actual revenue of 0 and EPS of -2.517

Turnstone Biologics released FY2024 Q3 earnings on November 12 (EST), actual EPS -0.7393 (forecast -0.86)

Rich Sparkle

Novabay Pharmac

Valens Semiconductor

Greenpower Motor

Alpha Tech

Offerpad Solutions

VCI Global

Tryhard

Tradr 2X Long APLD Daily ETF

ZeZentalis Pharma

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Turnstone Biologics(TSBX.US)